BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 15364780)

  • 1. Clinical correlation of asbestos bodies in BAL fluid.
    Vathesatogkit P; Harkin TJ; Addrizzo-Harris DJ; Bodkin M; Crane M; Rom WN
    Chest; 2004 Sep; 126(3):966-71. PubMed ID: 15364780
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Simple evaluation of numbers of asbestos bodies in bronchoalveolar lavage fluid under light microscopy: analysis of 35 pulmonary nodular lesions].
    Kawahara K; Kawasumi H; Nagano T; Sasada S; Okamoto N
    Rinsho Byori; 2008 Apr; 56(4):290-6. PubMed ID: 18516963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Distribution of asbestos bodies in the human lung as determined by bronchoalveolar lavage.
    Teschler H; Konietzko N; Schoenfeld B; Ramin C; Schraps T; Costabel U
    Am Rev Respir Dis; 1993 May; 147(5):1211-5. PubMed ID: 8484633
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Longitudinal changes in lung function among asbestos-exposed workers.
    Schwartz DA; Davis CS; Merchant JA; Bunn WB; Galvin JR; Van Fossen DS; Dayton CS; Hunninghake GW
    Am J Respir Crit Care Med; 1994 Nov; 150(5 Pt 1):1243-9. PubMed ID: 7952547
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The content of asbestos bodies in the bronchoalveolar fluid as a parameter of an increased pulmonary asbestos load].
    Teschler H; Hoheisel G; Fischer M; Müller KM; Konietzko N; Costabel U
    Dtsch Med Wochenschr; 1993 Dec; 118(48):1749-54. PubMed ID: 8253027
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Asbestos bodies in bronchoalveolar lavage fluid and in lung parenchyma.
    Sebastien P; Armstrong B; Monchaux G; Bignon J
    Am Rev Respir Dis; 1988 Jan; 137(1):75-8. PubMed ID: 3337472
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Relevance of asbestos bodies in sputum.
    Teschler H; Thompson AB; Dollenkamp R; Konietzko N; Costabel U
    Eur Respir J; 1996 Apr; 9(4):680-6. PubMed ID: 8726931
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The clinical utility and reliability of asbestos bodies in bronchoalveolar fluid.
    Schwartz DA; Galvin JR; Burmeister LF; Merchant RK; Dayton CS; Merchant JA; Hunninghake GW
    Am Rev Respir Dis; 1991 Sep; 144(3 Pt 1):684-8. PubMed ID: 1892311
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do asbestos-related pleural plaques on HRCT scans cause restrictive impairment in the absence of pulmonary fibrosis?
    Clin B; Paris C; Ameille J; Brochard P; Conso F; Gislard A; Laurent F; Letourneux M; Luc A; Schorle E; Pairon JC
    Thorax; 2011 Nov; 66(11):985-91. PubMed ID: 21724747
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The clinical utility of asbestos body counts in bronchoalveolar lavage fluid].
    Takabe K; Tsukada Y; Shimizu T; Takagiwa J; Hirayama M; Nakayama M; Miura H; Akabane H; Takayama S; Aida S
    Nihon Kyobu Shikkan Gakkai Zasshi; 1997 Nov; 35(11):1196-204. PubMed ID: 9493446
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Association between neutrophil concentration in bronchoalveolar lavage fluid and recent losses in diffusing capacity in men formerly exposed to asbestos.
    Cullen MR; Merrill WW
    Chest; 1992 Sep; 102(3):682-7. PubMed ID: 1516387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of Bronchoalveolar Lavage for the Diagnosis of Asbestos-Related Diseases.
    Cruz MJ; Curull V; Pijuan L; Álvarez-Simón D; Sánchez-Font A; de Gracia J; Culebras M; Ferrer J
    Arch Bronconeumol; 2017 Jun; 53(6):318-323. PubMed ID: 27914752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diagnostic value of asbestos bodies in bronchoalveolar lavage fluid.
    De Vuyst P; Dumortier P; Moulin E; Yourassowsky N; Yernault JC
    Am Rev Respir Dis; 1987 Nov; 136(5):1219-24. PubMed ID: 3314616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Significance of bronchoalveolar lavage in demonstrating previous exposure to asbestos].
    Rivolta G; Prandi E; Sogliani M; Picchi O
    Med Lav; 2001; 92(3):166-72. PubMed ID: 11515149
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High prevalence of reversible airway obstruction in asbestos-exposed workers.
    Delpierre S; Delvolgo-Gori MJ; Faucher M; Jammes Y
    Arch Environ Health; 2002; 57(5):441-5. PubMed ID: 12641187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunocytological and mineralogical study of bronchoalveolar lavage in a group of subjects exposed to asbestos.
    Brunetti G; Delmastro M; Fonte R; Moscato G; Bossi A; Baiardi P; Massola A; Meloni F
    G Ital Med Lav Ergon; 2003; 25(2):152-60. PubMed ID: 12872499
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal decline in lung function in former asbestos exposed workers.
    Algranti E; Mendonça EM; Hnizdo E; De Capitani EM; Freitas JB; Raile V; Bussacos MA
    Occup Environ Med; 2013 Jan; 70(1):15-21. PubMed ID: 23014595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pulmonary function, smoking habits, and high resolution computed tomography (HRCT) early abnormalities of lung and pleural fibrosis in shipyard workers exposed to asbestos.
    Neri S; Boraschi P; Antonelli A; Falaschi F; Baschieri L
    Am J Ind Med; 1996 Nov; 30(5):588-95. PubMed ID: 8909607
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Asbestos bodies in bronchoalveolar lavage fluid and sputum.
    Capellaro E; Chiesa A; Villari S; Bontempi S; Sulotto F; Scansetti G
    Med Lav; 1997; 88(2):99-107. PubMed ID: 9258005
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Frequency and risk of bronchopulmonary neoplasia related to asbestos].
    Badorrey MI; Monsó E; Teixidó A; Pifarré R; Rosell A; Llatjós M
    Med Clin (Barc); 2001 Jun; 117(1):1-6. PubMed ID: 11440692
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.